LATEST

• REGULATORY LDP, Ishin Near Deal on Chuikyo Reform to Bolster Drug Discovery
  July 7, 2026

• BUSINESS Astellas Confirms Applying to US MFN Medicaid Pricing Model
  July 7, 2026

• REGULATORY Govt Eyes Honebuto Revisions on Biosimilars, MFN Policy
  July 7, 2026

• BUSINESS Otsuka’s Astex Inks Breast Cancer R&D Pact with Genentech
  July 7, 2026

• REGULATORY JMA Chief Calls for Subsidies, Tax Breaks to Boost Domestic Drug Production
  July 7, 2026

• REGULATORY LDP Launches Alzheimer’s League, Experts Call for Earlier Intervention
  July 7, 2026

• BUSINESS Ribomic, Fujifilm to Join Forces on LNP CDMO Services
  July 7, 2026

• BUSINESS Toray Unveils Next-Generation Opioid Painkiller Candidate
  July 7, 2026

• BUSINESS Keytruda’s No. 1 Streak Reaches 33 Months: Encise
  July 7, 2026

• BUSINESS Takeda Rolls Out Higher-Concentration Kenketu Glovenin-I 10%
  July 7, 2026

• ORGANIZATION Labor Group Urges Govt to Scrap FY2027 Off-Year Drug Price Cuts
  July 7, 2026

• COMMENTARY DORA Use Could Expand as Japan Opens Door to “Sleep Disorders” Specialty
  July 6, 2026

• BUSINESS Tanabe to Sell Manufacturing Unit to Towa, Transfer 17 Products
  July 6, 2026

• ORGANIZATION Japan’s Contract Rep Workforce Hits Record High in FY2025
  July 6, 2026

• BUSINESS Espha Launches Generic Forxiga; Nipro AG Due in September
  July 6, 2026

• ORGANIZATION Japan’s Generic Use Rate Climbs to 89.7% in FY2025: JGA
  July 6, 2026

• REGULATORY Japan, US Launch Talks on Pharma GMP MRA to Ease Inspection Burden
  July 3, 2026

• BUSINESS GNI Targets Above-Industry Growth in Japan after Ayumi Buyout
  July 3, 2026

• REGULATORY MHLW Gives Kissei until July 21 to Report on Tavneos
  July 3, 2026

• REGULATORY Centrist Reform Alliance Warns US MFN Policy Poses “Real Crisis” for Drug Access
  July 3, 2026

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »